Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?

Pharmaceuticals (Basel) · 2021 · PMC8538435 · PMID 34681280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This might be seen in contrast to a recent analysis of emergency department admissions that showed a trend towards a combined PGx risk profile of low activity CYP2C9 and VKORC1 genotypes being associated with phenprocoumon-induced bleeding ADRs [ 29 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.